125 related articles for article (PubMed ID: 4132674)
1. Letter: The treatment of Graves disease.
JAMA; 1974 May; 228(8):976. PubMed ID: 4132674
[No Abstract] [Full Text] [Related]
2. [Effect of radical treatment of Basedow's disease on the ocular symptoms].
Lederer J
Ann Endocrinol (Paris); 1974; 35(1):79-81. PubMed ID: 4138226
[No Abstract] [Full Text] [Related]
3. [Current concepts in the treatment of Basedow's disease].
Jaffiol C; Baldet L
Sem Hop; 1975 Sep 10-20; 51(37-38):2265-7. PubMed ID: 56038
[No Abstract] [Full Text] [Related]
4. Controversies in the management of Graves' disease.
Leech NJ; Dayan CM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):273-80. PubMed ID: 9861313
[No Abstract] [Full Text] [Related]
5. Emerging pharmacotherapy for treatment of Graves' disease.
Bahn RS
Expert Rev Clin Pharmacol; 2012 Nov; 5(6):605-7. PubMed ID: 23234319
[No Abstract] [Full Text] [Related]
6. [Treatment of Basedow's disease].
Bürgi H
Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173
[No Abstract] [Full Text] [Related]
7. [The ocular risks of treatment of Basedow's disease (author's transl)].
Mornex R; Pousset G; Guinet P
Ann Endocrinol (Paris); 1974; 35(1):74-8. PubMed ID: 4138066
[No Abstract] [Full Text] [Related]
8. Graves' disease in children.
Hung W
Curr Ther Endocrinol Metab; 1997; 6():77-81. PubMed ID: 9174708
[No Abstract] [Full Text] [Related]
9. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment.
Rivkees SA; Sklar C; Freemark M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3767-76. PubMed ID: 9814445
[No Abstract] [Full Text] [Related]
10. [Complex treatment of toxic goiter].
Kal'chenko II; Nechiporenko FP
Sov Med; 1973 Oct; 36(10):99-102. PubMed ID: 4133131
[No Abstract] [Full Text] [Related]
11. Letter: The treatment of Graves disease.
Caswell HT; Maier WP
JAMA; 1974 Feb; 227(8):939-40. PubMed ID: 4129956
[No Abstract] [Full Text] [Related]
12. Hyperthyroidism.
Helling TJ
Lancet; 2003 Nov; 362(9395):1584-5. PubMed ID: 14615127
[No Abstract] [Full Text] [Related]
13. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
Rasmussen AK; Feldt-Rasmussen UF
Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
[No Abstract] [Full Text] [Related]
14. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
[TBL] [Abstract][Full Text] [Related]
15. Antithyroid drugs.
Nebesio TD; Eugster EA
N Engl J Med; 2005 May; 352(21):2246-7; author reply 2246-7. PubMed ID: 15926207
[No Abstract] [Full Text] [Related]
16. [Basedow's disease. Individual therapy of is great significance].
Hörmann R
MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
[No Abstract] [Full Text] [Related]
17. [Current approaches to the treatment of diffuse toxic goiter].
Balabolkin MI
Ter Arkh; 1995; 67(10):15-8. PubMed ID: 8779095
[No Abstract] [Full Text] [Related]
18. [Therapy of Basedow's disease].
Burger AG
Schweiz Rundsch Med Prax; 1988 Feb; 77(7):143-5. PubMed ID: 2451854
[No Abstract] [Full Text] [Related]
19. [Drug treatment of Graves' ophthalmopathy].
Prummel MF; Wiersinga WM
Ned Tijdschr Geneeskd; 1990 May; 134(19):938-40. PubMed ID: 1693417
[No Abstract] [Full Text] [Related]
20. Preventing Graves' ophthalmopathy.
Wiersinga WM
N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
